A new drug, OCT2013, was found in animal experiments to prevent lethal arrhythmias and ventricular fibrillation as effectively as lidocaine but without lidocaine's severe side effects.
Feb 16, 2022
0
28
A new study has found women 'age' significantly faster in the perimenopausal period, based on analysis of the IgG glycome. This finding indicates the potential of using the IgG glycome composition as an early predictor for ...
Feb 11, 2022
0
3
Essential new guidelines to design mechanical ventilators that can work in low- and middle-income countries (LMICs) have been proposed.
Feb 10, 2022
0
3
It is estimated that around 1.25 million people in the UK alone suffer from an eating disorder, with onset most commonly occurring in adolescence or young adulthood. Throughout the last few decades, eating disorders have ...
Feb 10, 2022
0
3
A team of researchers from the King's College London Schools of Cancer & Pharmaceutical Sciences and Immunology and Microbial Sciences and the Cancer Systems Biology laboratory at the Francis Crick Institute, led by Professor ...
Feb 9, 2022
0
17
In a new study researchers from the School of Biomedical Engineering & Imaging Sciences, in collaboration with the Noninvasive Surgery & Biopsy Laboratory led by Dr. James Choi at Imperial College London, have found that ...
Feb 4, 2022
0
74
New research from the Institute of Psychiatry, Psychology, & Neuroscience (IoPPN) at King's College London has found that young people who experience loneliness during early adolescence (age 12) are at greater risk of leaving ...
Feb 3, 2022
0
3
Researchers from the School of Biomedical Engineering & Imaging Sciences and Oxford University have identified the specific 3D pattern that is linked to the risks after an infarct, when tissue dies due to inadequate blood ...
Jan 27, 2022
0
0
New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London suggests that a virtual reality test in which participants "go to the shops" could offer a potentially promising way ...
Jan 26, 2022
0
49
Heparin, a widely available and affordable drug, has found to limit lung damage when inhaled by COVID-19 patients.
Jan 21, 2022
0
29
